Allergan

3 Biotechs Facing FDA Approvals by Year's End
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
FDA
Amgen
Vascepa
Allergan
migraines
ubrogepant
Intra-Cellular Therapies
lumateperone
schizophrenia
Flag link:
Go or no go? Vascepa’s finale and Allergan's pain relief
Go or no go? Vascepa’s finale and Allergan's pain relief
EP Vantage
FDA
Amarin
Vascepa
Allergan
migraines
ubrogepant
Flag link:
Before 2019 closes, the FDA has 3 key approval decisions to make
Before 2019 closes, the FDA has 3 key approval decisions to make
Biopharma Dive
Allergan
ubrogepant
migraines
Amarin
Vascepa
Intra-Cellular Therapeutics
lumateperone
schizophrenia
bipolar disorder
drug approvals
FDA
Flag link:
AbbVie's new launches Skyrizi, Rinvoq aren't getting enough credit: analyst
AbbVie's new launches Skyrizi, Rinvoq aren't getting enough credit: analyst
Fierce Pharma
AbbVie
Skyrizi
Rinvoq
Allergan
drug launches
Flag link:
AbbVie Shareholders Have a Lot to Look Forward To With Allergan
AbbVie Shareholders Have a Lot to Look Forward To With Allergan
Motley Fool
AbbVie
Allergan
earnings
M&A
Flag link:
Allergan builds case for migraine drug ubrogepant as FDA verdict nears
Allergan builds case for migraine drug ubrogepant as FDA verdict nears
Pharmaforum
Allergan
migraines
ubrogepant
FDA
Flag link:
Top 10 pharma settlements since 2018
Top 10 pharma settlements since 2018
Fierce Pharma
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
Flag link:
Allergan enlists Exicure in search of hair loss drugs with $25M upfront, doubling down on area dear to AbbVie
Allergan enlists Exicure in search of hair loss drugs with $25M upfront, doubling down on area dear to AbbVie
Endpoints
Allergan
AbbVie
R&D
hair loss
Exicure
Flag link:
With Allergan megamerger looming, AbbVie plots massive $28B bond offering: Bloomberg
With Allergan megamerger looming, AbbVie plots massive $28B bond offering: Bloomberg
Fierce Pharma
AbbVie
Allergan
M&A
Flag link:
AbbVie may count on Allergan's Botox for post-merger growth. But what else?
AbbVie may count on Allergan's Botox for post-merger growth. But what else?
Fierce Pharma
Allergan
AbbVie
M&A
Botox
Flag link:
Allergan (AGN) Q3 Earnings Meet Estimates
Allergan (AGN) Q3 Earnings Meet Estimates
Yahoo/Zacks.com
Allergan
earnings
Flag link:
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Allergan
Regeneron
Mylan
Catalent
Jazz Pharmaceuticals
Flag link:
WIll Allergan (AGN) Beat Estimates This Earnings Season?
WIll Allergan (AGN) Beat Estimates This Earnings Season?
Yahoo/Zacks.com
Allergan
earnings
Flag link:
AbbVie says multiple parties vying for assets related to Allergan deal approval
AbbVie says multiple parties vying for assets related to Allergan deal approval
Yahoo/Reuters
AbbVie
Allergan
Zenprep
brazikumab
M&A
Flag link:
Allergan pays $750m to avoid Alzheimer’s drug lawsuit
Allergan pays $750m to avoid Alzheimer’s drug lawsuit
Pharmaforum
Allergan
Namenda
Alzheimer's disease
settlement
Flag link:
Allergan backs mobile app for breast implant info exchange between patients and plastic surgeons
Allergan backs mobile app for breast implant info exchange between patients and plastic surgeons
Fierce Pharma
Allergan
breast implants
mobile apps
patients
devices
physicians
Flag link:
Allergan’s Botox Approved for Lower Limb Spasticity in Pediatric Patients
Allergan’s Botox Approved for Lower Limb Spasticity in Pediatric Patients
BioSpace
pediatrics
Allergan
FDA
Botox
lower limb spasticity
Flag link:
Another hit for AbbVie: Unexpected $673M Irish tax bill adds to Allergan merger woes
Another hit for AbbVie: Unexpected $673M Irish tax bill adds to Allergan merger woes
Fierce Pharma
Allergan
AbbVie
Ireland
taxes
M&A
Flag link:
AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending
AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending
Fierce Pharma
DTC ads
television ads
AbbVie
Humira
Gilead Sciences
Truvada
Allergan
Botox
Flag link:
AbbVie Stays Busy While Working to Complete Allergan Acquisition
AbbVie Stays Busy While Working to Complete Allergan Acquisition
BioSpace
AbbVie
Allergan
M&A
Skyrizi
Reata Pharmaceuticals
Flag link:

Pages